Sign in

NCT04553809Completed

Navigation Endobronchial Ultrasound

The Efficacy of Combining Endoscopic Modalities for the Diagnosis of Solitary Pulmonary Lesions

Source: ClinicalTrials.gov · Last updated 14 May 2025

Brief summary (registry, in English)

Lung cancer is the primary cause of cancer related deaths in Denmark. In order to improve the prognosis diagnosis in earlier stages are needed. This will however require improved sampling techniques from very small lung lesions. One method involves the use of a radial ultrasound probe inserted in the working channel of the bronchoscope, to more accurately identify the lung lesions before sampling them (rEBUS). The other method involves the use of electromagnetic navigation bronchoscopy (ENB) to guide the operator to the lung lesion. This study aims to determine whether a combination of rEBUS and ENB is superior to ENB alone in biopsy sampling. The study will be conducted as a non-blinded RCT. Furthermore, we will make an estimate of the hospital costs of the entire diagnostic work up for lung cancer when combining ENB and rEBUS compared to ENB alone.

Status (registry)
Completed
Study type
Interventional
Enrollment
200 (actual)
First submitted
3 Sept 2020
Start date
12 Oct 2020
Primary completion date
30 Aug 2024
Lead sponsor
Amanda Dandanell Juul
Diseases
Lung cancer
NCT number
NCT04553809

What you commit to

  • Study type: Interventional
  • Participants enrolled: 200
  • From 12 Oct 2020 to the primary completion date, 30 Aug 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Patient has medical devices in which ENB is contraindicated (e.g. implanted pacemaker or defibrillator)
  • Pregnancy

Who the study is looking for

  • Examination for lung cancer
  • Peripheral lung lesion or lung nodule surrounded by normal lung parenchyma
  • Written and orally informed consent

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Departement of respiratory medicin
Coordinator of this site? Confirm its status
OdenseDenmarkUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.